US 11512052
Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
granted A61PA61P25/28
Quick answer
US patent 11512052 (Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury) held by United States Government as represented by the Department of Veterans Affairs expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P25/28